Published in Cardiovasc Drugs Ther on March 01, 1991
Epigallocatechin, a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in rats. Mol Med (2004) 1.12
Reduction of oxidative stress does not affect recovery of myocardial function: warm continuous versus cold intermittent blood cardioplegia. Heart (1997) 0.86
Urinary metals and heart rate variability: a cross-sectional study of urban adults in Wuhan, China. Environ Health Perspect (2014) 0.83
Evidence that continuous normothermic blood cardioplegia offers better myocardial protection than intermittent hypothermic cardioplegia. Br Heart J (1995) 0.81
Protective effect of edaravone against hypoxia-reoxygenation injury in rabbit cardiomyocytes. Br J Pharmacol (2004) 0.81
Reperfusion Injury: Does It Exist and Does It Have Clinical Relevance? J Thromb Thrombolysis (1997) 0.78
Changes in proton transverse relaxation times of rat myocardium that has suffered a previous oxidative insult. MAGMA (1997) 0.76
Myocardial stunning--are calcium antagonists useful? Cardiovasc Drugs Ther (1994) 0.76
The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J (1973) 7.01
The stunned myocardium: prolonged, postischemic ventricular dysfunction. Circulation (1982) 5.56
Direct measurement of free radical generation following reperfusion of ischemic myocardium. Proc Natl Acad Sci U S A (1987) 4.87
Myocardial reperfusion: a double-edged sword? J Clin Invest (1985) 4.12
Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog. Circulation (1983) 4.01
Myocardial necrosis induced by temporary occlusion of a coronary artery in the dog. Arch Pathol (1960) 3.09
Alpha adrenergic contributions to dysrhythmia during myocardial ischemia and reperfusion in cats. J Clin Invest (1980) 2.41
Reversible ischemic left ventricular dysfunction: evidence for the "hibernating myocardium". J Am Coll Cardiol (1986) 2.20
Molecular oxygen: friend and foe. The role of the oxygen free radical system in the calcium paradox, the oxygen paradox and ischemia/reperfusion injury. J Mol Cell Cardiol (1984) 2.03
Demonstration of free radical generation in "stunned" myocardium of intact dogs with the use of the spin trap alpha-phenyl N-tert-butyl nitrone. J Clin Invest (1988) 2.02
Reperfusion-induced arrhythmias: mechanisms and prevention. J Mol Cell Cardiol (1984) 2.00
Xanthine oxidase as a source of free radical damage in myocardial ischemia. J Mol Cell Cardiol (1985) 2.00
The oxygen paradox and the calcium paradox: two facets of the same problem? J Mol Cell Cardiol (1978) 1.95
Evidence for the presence of a reversible Ca2+-dependent pore activated by oxidative stress in heart mitochondria. Biochem J (1987) 1.92
Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog. Proc Natl Acad Sci U S A (1989) 1.90
Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: a study of myocardial enzyme release. J Mol Cell Cardiol (1973) 1.77
Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. Circ Res (1987) 1.74
Reperfusion of the ischemic myocardium. J Mol Cell Cardiol (1977) 1.74
Reperfusion injury and its pharmacologic modification. Circulation (1989) 1.67
Enhancement of recovery of myocardial function by oxygen free-radical scavengers after reversible regional ischemia. Circulation (1985) 1.54
Reperfusion-induced arrhythmias and oxygen-derived free radicals. Studies with "anti-free radical" interventions and a free radical-generating system in the isolated perfused rat heart. Circ Res (1986) 1.52
Reperfusion arrhythmia: a marker of restoration of antegrade flow during intracoronary thrombolysis for acute myocardial infarction. Am Heart J (1983) 1.42
Volume regulation and plasma membrane injury in aerobic, anaerobic, and ischemic myocardium in vitro. Effects of osmotic cell swelling on plasma membrane integrity. Circ Res (1985) 1.39
Ischemia and reperfusion-induced arrhythmias in the rat. Effects of xanthine oxidase inhibition with allopurinol. Circ Res (1984) 1.39
Prolonged depletion of ATP and of the adenine nucleotide pool due to delayed resynthesis of adenine nucleotides following reversible myocardial ischemic injury in dogs. J Mol Cell Cardiol (1981) 1.37
Myocardial ischemia revisited. The osmolar load, membrane damage, and reperfusion. J Mol Cell Cardiol (1986) 1.32
Beneficial actions of superoxide dismutase and catalase in stunned myocardium of dogs. Am J Physiol (1986) 1.27
Effect of some free radical scavengers on reperfusion induced arrhythmias in the isolated rat heart. J Mol Cell Cardiol (1985) 1.21
Attenuation of dysfunction in the postischemic 'stunned' myocardium by dimethylthiourea. Circulation (1987) 1.17
Oxygen-derived free radicals and postischemic myocardial dysfunction ("stunned myocardium"). J Am Coll Cardiol (1988) 1.17
The role of the neutrophil and free radicals in ischemic myocardial injury. J Mol Cell Cardiol (1989) 1.16
O2 free radicals: cause of ischemia-reperfusion injury to cardiac Na+-K+-ATPase. Am J Physiol (1987) 1.15
Potential oxidative pathways of catecholamines in the formation of lipid peroxides and genesis of heart disease. Adv Exp Med Biol (1983) 1.15
Superoxide dismutase plus catalase improve contractile function in the canine model of the "stunned myocardium". Circ Res (1986) 1.15
Time course and determinants of recovery of function after reversible ischemia in conscious dogs. Am J Physiol (1988) 1.14
Laser flash photokinetic studies of rose bengal sensitized photodynamic interactions of nucleotides and DNA. Photochem Photobiol (1987) 1.12
Spin-trapping evidence that graded myocardial ischemia alters post-ischemic superoxide production. Free Radic Biol Med (1987) 1.10
Free radicals and reperfusion-induced arrhythmias: protection by spin trap agent PBN in the rat heart. Circ Res (1987) 1.08
Iron-load increases the susceptibility of rat hearts to oxygen reperfusion damage. Protection by the antioxidant (+)-cyanidanol-3 and deferoxamine. Circulation (1988) 1.08
Redox modification of sodium-calcium exchange activity in cardiac sarcolemmal vesicles. J Biol Chem (1986) 1.07
Cyclic AMP levels in ischaemic and non-ischaemic myocardium following coronary artery ligation: relation to ventricular fibrillation. J Mol Cell Cardiol (1978) 1.06
Ultrastructural damage associated with reoxygenation of the anoxic myocardium. J Mol Cell Cardiol (1975) 1.06
Differing mechanisms for ventricular vulnerability during coronary artery occlusion and release. Am Heart J (1976) 1.05
Myocardial consequences of reperfusion. Prog Cardiovasc Dis (1987) 1.04
N-2-mercaptopropionylglycine improves recovery of myocardial function after reversible regional ischemia. J Am Coll Cardiol (1986) 0.97
Ventricular fibrillation caused by myocardial reperfusion in Prinzmetal's angina. Am Heart J (1983) 0.97
Electrophysiological derangements induced by lipid peroxidation in cardiac tissue. Am J Physiol (1987) 0.97
Free radical scavengers in myocardial ischemia. Fed Proc (1987) 0.96
Can superoxide dismutase alter myocardial infarct size? Circulation (1989) 0.95
A protective effect of coenzyme Q10 on ischemia and reperfusion of the isolated perfused rat heart. J Mol Cell Cardiol (1981) 0.93
Oxygen-induced enzyme release: early events and a proposed mechanism. J Mol Cell Cardiol (1979) 0.92
Reperfusion-induced arrhythmias and free radicals: studies in the rat heart with DMPO. J Cardiovasc Pharmacol (1987) 0.91
The role of neutrophils and free radicals in the ischemic-reperfused heart: why the confusion and controversy? J Mol Cell Cardiol (1989) 0.90
Reperfusion-induced arrhythmias: a study of the role of xanthine oxidase-derived free radicals in the rat heart. J Mol Cell Cardiol (1988) 0.87
Reactive oxygen species modify the structure and function of the cardiac sarcoplasmic reticulum calcium-release channel. Cardioscience (1991) 0.87
Singlet oxygen and myocardial injury: ultrastructural, cytochemical and electrocardiographic consequences of photoactivation of rose bengal. J Mol Cell Cardiol (1990) 0.83
Ischemia, reperfusion, and the determinants of tissue injury. Cardiovasc Drugs Ther (1990) 0.83
Singlet oxygen-induced arrhythmias. Dose- and light-response studies for photoactivation of rose bengal in the rat heart. Circulation (1989) 0.82
Effect of superoxide dismutase plus catalase on myocardial infarct size in rabbits. Can J Cardiol (1989) 0.81
Functional and electrophysiological effects of oxidant stress on isolated ventricular muscle: a role for oscillatory calcium release from sarcoplasmic reticulum in arrhythmogenesis? Cardiovasc Res (1991) 0.80
The role of xanthine oxidase during myocardial ischemia in several species including man. J Mol Cell Cardiol (1988) 0.79
Photophysical properties of rose bengal and its derivatives (XII). J Free Radic Biol Med (1985) 0.79
Superoxide dismutase and the reduction of reperfusion-induced arrhythmias: in vivo dose-response studies in the rat. Cardiovasc Drugs Ther (1987) 0.79
Dimethylthiourea, but not dimethylsulfoxide, reduces canine myocardial infarct size. Free Radic Biol Med (1989) 0.78
The role of lipid peroxidation in pathogenesis of arrhythmias and prevention of cardiac fibrillation with antioxidants. Basic Res Cardiol (1987) 0.78
Rapid electrophysiological changes leading to arrhythmias in the aerobic rat heart. Photosensitization studies with rose bengal-derived reactive oxygen intermediates. Circ Res (1989) 0.77
Reperfusion-induced arrhythmias in the isolated rabbit heart: characterization of the influence of the duration of regional ischemia and the extracellular potassium concentration. J Mol Cell Cardiol (1988) 0.77
Protection afforded by allopurinol in the first 24 hours of coronary occlusion is diminished after 48 hours. Free Radic Biol Med (1988) 0.77
Effects of allopurinol pretreatment on myocardial ultrastructure and arrhythmias following coronary artery occlusion and reperfusion. Virchows Arch B Cell Pathol Incl Mol Pathol (1986) 0.76
The protection of the ischemic myocardium: surgical success v clinical failure? Prog Cardiovasc Dis (1988) 0.75
The role of phospholipase in the genesis of reperfusion arrhythmia. J Electrocardiol (1986) 0.75
Antioxidants as antiarrhythmic drugs. Cardiology (1987) 0.75
Protection of reperfused ischemic canine myocardium by CI-922, a new inhibitor of leukocyte activation. J Cardiovasc Pharmacol (1988) 0.75
Activation of ATP-sensitive potassium channels: a novel pharmacological approach to myocardial protection? Cardiovasc Res (1995) 1.69
Hibernation: a form of endogenous protection? Six questions for investigation. Basic Res Cardiol (1997) 0.75